Suppr超能文献

重新定义主要的花生过敏原。

Redefining the major peanut allergens.

机构信息

Division of Allergy and Clinical Immunology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.

出版信息

Immunol Res. 2013 Mar;55(1-3):125-34. doi: 10.1007/s12026-012-8355-x.

Abstract

Food allergy has become a major public health concern in westernized countries, and allergic reactions to peanuts are particularly common and severe. Allergens are defined as antigens that elicit an IgE response, and most allergenic materials (e.g., pollens, danders, and foods) contain multiple allergenic proteins. This has led to the concept that there are "major" allergens and allergens of less importance. "Major allergens" have been defined as allergens that bind a large amount of IgE from the majority of patients and have biologic activity. However, the ability of an allergen to cross-link complexes of IgE and its high-affinity receptor FcεRI (IgE/FcεRI), which we have termed its allergic effector activity, does not correlate well with assays of IgE binding. To identify the proteins that are the most active allergens in peanuts, we and others have employed in vitro model assays of allergen-mediated cross-linking of IgE/FcεRI complexes and have demonstrated that the most potent allergens are not necessarily those that bind the most IgE. The importance of a specific allergen can be determined by measuring the allergic effector activity of that allergen following purification under non-denaturing conditions and by specifically removing the allergen from a complex allergenic extract either by chromatography or by specific immunodepletion. In our studies of peanut allergens, our laboratory has found that two related allergens, Ara h 2 and Ara h 6, together account for the majority of the effector activity in a crude peanut extract. Furthermore, murine studies demonstrated that Ara h 2 and Ara h 6 are not only the major elicitors of anaphylaxis in this system, but also can effectively desensitize peanut-allergic mice. As a result of these observations, we propose that the definition of a major allergen should be based on the potency of that allergen in assays of allergic effector activity and demonstration that removal of that allergen from an extract results in loss of potency. Using these criteria, Ara h 2 and Ara h 6 are the major peanut allergens.

摘要

食物过敏已成为西方国家主要的公共卫生问题,而花生过敏尤其常见且严重。过敏原被定义为能引起 IgE 反应的抗原,大多数过敏原物质(如花粉、皮屑和食物)都含有多种过敏原蛋白。这就产生了“主要”过敏原和不太重要的过敏原的概念。“主要过敏原”被定义为能与大多数患者的大量 IgE 结合并具有生物活性的过敏原。然而,过敏原与 IgE 及其高亲和力受体 FcεRI(IgE/FcεRI)交联复合物的能力及其过敏效应活性与其 IgE 结合测定并不相符。为了确定花生中最活跃的过敏原蛋白,我们和其他人采用了体外模型测定过敏原介导的 IgE/FcεRI 复合物交联,并证明最有效的过敏原不一定是与最多 IgE 结合的过敏原。特定过敏原的重要性可以通过在非变性条件下纯化后测量该过敏原的过敏效应活性,并通过色谱或特异性免疫耗竭从复杂的变应原提取物中特异性去除过敏原来确定。在我们对花生过敏原的研究中,我们实验室发现两种相关的过敏原 Ara h 2 和 Ara h 6 共同构成了粗花生提取物中大多数效应活性的来源。此外,鼠类研究表明,Ara h 2 和 Ara h 6 不仅是该系统中过敏反应的主要引发剂,而且还可以有效地使花生过敏的小鼠脱敏。基于这些观察结果,我们提出主要过敏原的定义应基于该过敏原在过敏效应活性测定中的效力以及从提取物中去除该过敏原会导致效力丧失的证据。使用这些标准,Ara h 2 和 Ara h 6 是主要的花生过敏原。

相似文献

1
Redefining the major peanut allergens.
Immunol Res. 2013 Mar;55(1-3):125-34. doi: 10.1007/s12026-012-8355-x.
2
Natural clinical tolerance to peanut in African patients is caused by poor allergenic activity of peanut IgE.
Allergy. 2015 Jun;70(6):638-52. doi: 10.1111/all.12592. Epub 2015 Mar 22.
7
Conformational IgE epitopes of peanut allergens Ara h 2 and Ara h 6.
Clin Exp Allergy. 2016 Aug;46(8):1120-1128. doi: 10.1111/cea.12764. Epub 2016 Jun 27.
8
Effector activity of peanut allergens: a critical role for Ara h 2, Ara h 6, and their variants.
Clin Exp Allergy. 2009 Jul;39(7):1099-108. doi: 10.1111/j.1365-2222.2009.03273.x. Epub 2009 May 11.
10
Component-resolved IgE profiles in Austrian patients with a convincing history of peanut allergy.
Int Arch Allergy Immunol. 2015;166(1):13-24. doi: 10.1159/000371422. Epub 2015 Feb 27.

引用本文的文献

1
Characterization of IgE cross-reactivity and allergenicity of peanut allergens.
Immunohorizons. 2025 May 30;9(7). doi: 10.1093/immhor/vlaf018.
2
Heating Differentiates Pecan Allergen Stability: Car i 4 Is More Heat Labile Than Car i 1 and Car i 2.
Food Sci Nutr. 2025 Feb 16;13(2):e4747. doi: 10.1002/fsn3.4747. eCollection 2025 Feb.
3
Progress in genetic engineering and genome editing of peanuts: revealing the future of crop improvement.
Physiol Mol Biol Plants. 2024 Nov;30(11):1759-1775. doi: 10.1007/s12298-024-01534-6. Epub 2024 Dec 2.
4
Viral Vector Based Immunotherapy for Peanut Allergy.
Viruses. 2024 Jul 13;16(7):1125. doi: 10.3390/v16071125.
5
Multiplexed silencing of 2S albumin genes in peanut.
Plant Biotechnol J. 2024 Sep;22(9):2438-2440. doi: 10.1111/pbi.14357. Epub 2024 May 7.
6
Development and evaluation of mouse anti-Ara h 1 and Ara h 3 IgE monoclonal antibodies for advancing peanut allergy research.
MethodsX. 2023 Nov 4;11:102470. doi: 10.1016/j.mex.2023.102470. eCollection 2023 Dec.
7
A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1.
World Allergy Organ J. 2023 Nov 10;16(11):100839. doi: 10.1016/j.waojou.2023.100839. eCollection 2023 Nov.
8
Peanut Allergenicity: An Insight into Its Mitigation Using Thermomechanical Processing.
Foods. 2023 Mar 15;12(6):1253. doi: 10.3390/foods12061253.
9
Dose and route of administration determine the efficacy of prophylactic immunotherapy for peanut allergy in a Brown Norway rat model.
Front Immunol. 2023 Feb 23;14:1121497. doi: 10.3389/fimmu.2023.1121497. eCollection 2023.
10
Pea and lentil 7S globulin crystal structures with comparative immunoglobulin epitope mapping.
Food Chem (Oxf). 2022 Nov 17;5:100146. doi: 10.1016/j.fochms.2022.100146. eCollection 2022 Dec 30.

本文引用的文献

1
Ara h 2 and Ara h 6 have similar allergenic activity and are substantially redundant.
Int Arch Allergy Immunol. 2013;160(3):251-8. doi: 10.1159/000341642. Epub 2012 Oct 16.
2
Increasing the accuracy of peanut allergy diagnosis by using Ara h 2.
J Allergy Clin Immunol. 2012 Apr;129(4):1056-63. doi: 10.1016/j.jaci.2012.01.056. Epub 2012 Mar 3.
4
Peanut allergy: an evolving clinical challenge.
Discov Med. 2011 Oct;12(65):319-28.
5
Analysis of the effector activity of Ara h 2 and Ara h 6 by selective depletion from a crude peanut extract.
J Immunol Methods. 2011 Sep 30;372(1-2):65-70. doi: 10.1016/j.jim.2011.06.031. Epub 2011 Jul 18.
6
Molecular diagnosis of peanut and legume allergy.
Curr Opin Allergy Clin Immunol. 2011 Jun;11(3):222-8. doi: 10.1097/ACI.0b013e32834656c2.
7
Future therapies for food allergies.
J Allergy Clin Immunol. 2011 Mar;127(3):558-73; quiz 574-5. doi: 10.1016/j.jaci.2010.12.1098. Epub 2011 Jan 31.
8
Peanut allergy.
Curr Opin Pediatr. 2010 Oct;22(5):642-6. doi: 10.1097/MOP.0b013e32833d95cb.
9
Peanut varieties with reduced Ara h 1 content indicating no reduced allergenicity.
Mol Nutr Food Res. 2010 Mar;54(3):381-7. doi: 10.1002/mnfr.200900072.
10
Lipid transfer protein (Ara h 9) as a new peanut allergen relevant for a Mediterranean allergic population.
J Allergy Clin Immunol. 2009 Oct;124(4):771-8.e5. doi: 10.1016/j.jaci.2009.06.008. Epub 2009 Aug 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验